表紙
市場調査レポート

ファーマシーオートメーション:各種技術と世界市場

Pharmacy Automation: Technologies and Global Markets

発行 BCC Research 商品コード 133577
出版日 ページ情報 英文 212 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
ファーマシーオートメーション:各種技術と世界市場 Pharmacy Automation: Technologies and Global Markets
出版日: 2016年09月01日 ページ情報: 英文 212 Pages
概要

世界の入院患者・外来患者向けファーマシーオートメーション市場規模は、2015年の35億米ドルから2016年の約38億米ドルに拡大する見込みです。同市場は2016年から2021年の5年間に7.9%のCAGR (年間複合成長率) で成長し、2021年に55億米ドルへ達すると予測されています。

当レポートでは、入院患者および外来患者向け調剤自動化システムの世界市場について調査分析し、産業構造、市場影響因子、技術・製品、装置のコスト分析、競合構造、市場シェア、市場規模・成長率などをまとめ、ケーススタディ、主要企業のプロファイルなども盛り込み、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 産業概要

  • ファーマシーオートメーションの産業構造
  • ファーマシーオートメーション市場の背景、歴史、成長
    • 現在の薬剤デリバリーシステムを改善するための自動化の採用
    • 規制当局

第4章 市場に影響を及ぼす課題

  • バーコードと投薬の電子化
  • 有意義な活用:概要
  • 医療従事者の動向

第5章 入院患者への調剤の自動化

  • 市場概要
  • 状況の概要
    • 製品売上:エンドユーザー別
    • 救急処置
    • 長期ケア
  • 製品概要
    • 市場:製品タイプ別
    • 自動調剤/ストレージシステム
  • 自動パッケージングシステム
    • その他の自動化システム
    • 入院患者向け自動化のコスト:装置タイプ別
    • 市場:地域別
    • 競合構造・市場シェア

第6章 外来患者への調剤の自動化

  • 市場概要
  • 状況の概要
  • 市場:製品タイプ別
  • 製品説明
  • 外来患者向け自動化のコスト:装置タイプ別
  • 小売業者にとってのファーマシーオートメーションのメリット

第7章 世界のファーマシーオートメーション市場サマリー

  • 世界市場:セグメント別
  • 世界市場:装置タイプ別
  • 世界の市場シェア:セグメント別
  • 世界の市場シェア:装置タイプ別
  • 世界市場:地域別

第8章 技術

  • 概要
  • 現在の技術利用
  • 特許評価

第9章 企業プロファイル

  • ARXIUM
  • BAXTER INTERNATIONAL INC.
  • CAPSA SOLUTIONS LLC
  • BECTON, DICKINSON AND COMPANY
  • CERNER CORP.
  • EUCLID MEDICAL PRODUCTS
  • INNOVATION ASSOCIATES
  • MEDICAL PACKAGING INC.
  • OMNICELL INC.
  • PARATA SYSTEMS LLC
  • SCRIPTPRO LLC
  • SWISSLOG AG
  • TALYST INC.
  • TCGRX

第10章 付録

  • 付録I:主な装置メーカー
  • 付録II:その他の関連企業
  • 付録III:団体・組織など
  • 付録IV:州の統制薬物スケジューリング機関・その他の契約情報

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IAS026E

REPORT HIGHLIGHTS

The global inpatient and outpatient pharmacy automation market has grown to nearly $3.8 billion in 2016 from $3.5 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.9% from 2016 to 2021, increasing to $5.5 billion in 2021.

This report provides:

  • An overview of the global markets for pharmacy automation and related technologies
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • A market breakdown of inpatient pharmacy automation into acute-care settings and long-term care settings
  • A market breakdown of outpatient pharmacy automation into fast-track clinical settings, hospital retail settings, pharmacy benefit management services, and retail pharmacy chains
  • A look at the impact of chronic diseases, and growing and aging populations
  • Technology patent trends relating to automating processes in the pharmacy environment
  • Profiles of major players in the industry

SCOPE AND FORMAT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the global pharmacy automation market. The geographical scope is global with special emphasis on the United States and developed Europe, with supplemental data covering other geographical markets and trends. The report identifies pharmacy automation markets by inpatient and outpatient pharmacy settings, and by product type. Within the global pharmacy automation market, there are two general pharmacy settings, each having other subsettings:

  • Inpatient pharmacy automation.
    • Acute-care settings.
    • Long-term care settings.
  • Outpatient pharmacy automation.
    • Outpatient/fast-track clinical settings.
    • Hospital retail settings.
    • Pharmacy benefit management services and other mail-order settings.
    • Retail pharmacy chains.

Each segment is further reviewed to provide detailed information of current and emerging products, current market estimates and market forecasts, and competitive analyses.

ANALYST'S CREDENTIALS

Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health and emerging healthcare technologies. Ms. Elder has more than 20 years of experience in the healthcare industry, specializing in market research for the past 16 years. This experience has given her substantial insight into pharmaceutical and medical device market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • INTENDED AUDIENCE
  • SCOPE AND FORMAT
  • METHODOLOGY AND INFORMATION SOURCES
  • GLOSSARY OF PHARMACY-RELATED TERMS[1]
  • LIST OF COMMON ACRONYMS
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • MAJOR GLOBAL PHARMACY AUTOMATION MARKETS
  • SUMMARY TABLE GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, 2014-2021 ($ MILLIONS)
    • KEY TRENDS
    • LEADING MANUFACTURERS

CHAPTER 3 - INDUSTRY OVERVIEW

  • PHARMACY AUTOMATION INDUSTRY STRUCTURE
  • BACKGROUND, HISTORY AND GROWTH OF THE PHARMACY AUTOMATION MARKET
    • EMPLOYING AUTOMATION TO IMPROVE CURRENT MEDICATION DELIVERY SYSTEMS
      • Joint Commission Involvement
      • Common Prescribing Mistakes
        • TABLE 1: LIST OF ABBREVIATIONS USED IN MEDICAL PRESCRIPTIONS AND POSSIBLE CONFUSION MEANINGS
    • REGULATORY AUTHORITIES
      • Joint Commission of Accredited Healthcare Organizations (JCAHO or Joint Commission)
      • Food and Drug Administration (FDA)
      • European Medicines Agency (EMA)
      • European Federation of Pharmaceutical Industries and Associations (EFPIA)
      • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
      • Royal Pharmaceutical Society (RPS)
      • National Patient Safety Agency (NPSA)
      • Japanese Ministry of Health, Labor and Welfare (MHLW)
      • Central Drugs Standard Control Organization (CDSCO)
      • Therapeutic Goods Administration (TGA)
      • China Food and Drug Administration (CFDA)
      • Federal Trade Commission
      • Drug Enforcement Administration
      • National Association of Boards of Pharmacy (NABP)
      • ANVISA-Brazilian Health Surveillance Agency

CHAPTER 4 - ISSUES AFFECTING THE MARKET

  • BAR CODING AND ELECTRONIC MEDICATION ADMINISTRATION
  • MEANINGFUL USE: AN OVERVIEW
    • TABLE 2: ELECTRONIC HEALTHCARE "MEANINGFUL USE" STAGES BY CMS, 2011-2016
    • STANDARDIZATION OF BAR CODING
    • TRENDS IN RADIOFREQUENCY IDENTIFICATION DEVICES (RFID)
      • E-Pedigree Systems and RFID
  • HEALTHCARE PERSONNEL TRENDS
    • PHARMACY PERSONNEL
    • PHARMACISTS
      • Advanced Practice Pharmacies
      • Does Pharmacist Medication Therapy Management Result in Better Outcomes?
      • Pharmacist Occupational Outlook
      • Increasing Number of Pharmacists in Select Regions
    • PHARMACY TECHNICIANS
      • Pharmacy Technician Occupational Outlook
    • DIRECT CARE PROVIDERS
      • Nursing Occupational Outlook
    • CONSUMER ISSUES
      • Safety
      • Accuracy and Accountability
    • SAFETY ISSUES
      • FDA Reform Bill
      • Institute for Safe Medication Practices (ISMP)
      • Medication Administration Errors
        • TABLE 3: AVERAGE ANNUAL ADVERSE DRUG REACTIONS AND MEDICATION ADMINISTRATION ERRORS
        • TABLE 4: WIDELY REPORTED TYPES OF MEDICATION ERRORS
      • Organizational Structure and Its Effect on Errors
        • Surgical or Invasive Procedure Events
        • Product or Device Events
        • Patient Protection Events
        • Care Management Events
        • Environmental Events
        • Radiologic Events
        • Criminal Events
    • SHORT CYCLE DISPENSING-REQUIREMENTS FOR LONG-TERM CARE FACILITIES
    • IMPACT OF TELEPHARMACY
    • COMPLIANCE ISSUES
    • NARCOTICS MANAGEMENT AND TRACKING
      • FIGURE 1: OPIOID ANALGESIC OVERDOSE DEATHS, 1999 VS 2014 (NO. OF DEATHS)
      • TABLE 5: BENEFITS OF PRESCRIPTION MONITORING PROGRAMS FOR MEDICAL BOARDS
      • TABLE 6: STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS
      • FIGURE 2: NUMBER OF STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS, BY YEAR OF ENACTMENT, 1990--2012 (NO. OF STATES)
    • EHR INTEGRATION
      • TABLE 7: PERCENTAGE OF OFFICE-BASED PHYSICIANS USING ANY ELECTRONIC HEALTH RECORDS OR ELECTRONIC MEDICAL RECORDS, BY STATE, 2014* (%)
      • Aesynt AcuDose-Rx and Electronic Health Record Integration Capabilities
    • RETAIL PHARMACY ISSUES
    • IMPLEMENTATION ISSUES
    • BARRIERS TO IMPLEMENTATION
    • COST-EFFECTIVENESS IN PHARMACY AUTOMATION
      • Eyecon System and Lakeview Pharmacy
      • Parata Systems and Tara Pharmacy Case Study
      • TCGRx and Premier Pharmacy Services
      • Ohio Department of Mental Health
      • London Drugs
      • Med-Fast Pharmacy
      • U.S. Navy and ScriptPro's Telepharmacy Solution
      • Evergreen Hospital Medical Center
      • Leesburg Regional Medical Center
      • Miami Children's Hospital
      • Mountain View Hospital
      • Madera Medical Pharmacy
      • Lucile Packard Children's Hospital
      • UCSF Medical Center
      • St. Joseph Hospital
    • GLOBAL FINANCIAL CONDITIONS
      • Rising Healthcare Costs
        • TABLE 8: HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP, BY COUNTRY, 2008--2014 (%)
        • FIGURE 3: HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP, BY COUNTRY, 2008--2014* (%)
      • Pharmaceutical Expenditures
        • TABLE 9: PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES, BY COUNTRY, 2005--2013 (%)
        • TABLE 10: PHARMACEUTICAL EXPENDITURES PER CAPITA, BY COUNTRY, 2005--2013 ($)
    • WORLDWIDE POPULATION GROWTH
      • TABLE 11: BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%)
      • TABLE 12: LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015
      • TABLE 13: TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY AT AGE 65, 2015 (%)
      • TABLE 14: PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)
    • TRENDS IN HOSPITAL LENGTH OF STAY
      • TABLE 15: HOSPITAL UTILIZATION STATISTICS, 2003 AND 2013 (NO. OF DAYS)
      • FIGURE 4: HOSPITAL UTILIZATION STATISTICS, 2003 AND 2013 (NO. OF DAYS)
    • PUBLIC HEALTHCARE SYSTEMS AROUND THE WORLD

CHAPTER 5 - INPATIENT PHARMACY AUTOMATION

  • MARKET OVERVIEW
    • FIGURE 5: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, 2014--2021 ($ MILLIONS)
  • SETTING OVERVIEW
    • PRODUCT SALES BY END USER
      • FIGURE 6: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET SHARE, BY END USER, ESTIMATED 2016 (%)
    • ACUTE CARE SETTINGS
      • TABLE 16: ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE, BY SELECTED COUNTRY, 2015
      • FIGURE 7: ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS, BY SELECTED COUNTRY, 2015
    • LONG-TERM CARE SETTINGS
      • TABLE 17: LONG-TERM CARE AND NURSING HOMES BEDS AND RECIPIENTS, BY SELECTED COUNTRY, 2015 (NUMBER)
      • TABLE 18: HOSPICE FACTS, 2011-2014
  • PRODUCT OVERVIEW
    • MARKETS BY PRODUCT TYPE
      • TABLE 19: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
      • FIGURE 8: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014-2021 ($ MILLIONS)
    • AUTOMATED DISPENSING/STORAGE SYSTEMS
      • Narcotics and Anesthesia Management Systems
  • AUTOMATED PACKAGING SYSTEMS
    • OTHER AUTOMATED SYSTEMS
      • TABLE 20: SUMMARY OF INPATIENT PHARMACY AUTOMATION EQUIPMENT, BY MANUFACTURER AND EQUIPMENT TYPE
    • INPATIENT AUTOMATION COST BY EQUIPMENT TYPE
      • TABLE 21: INPATIENT PHARMACY AUTOMATION EQUIPMENT ANALYSIS
    • MARKETS BY WORLD REGION
      • TABLE 22: GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET, BY REGION, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 9: GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARE, BY REGION, ESTIMATED 2016 (%)
      • Level of Automation within Inpatient Pharmacy Settings
      • United States
        • TABLE 23: PERCENTAGE OF U.S. INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
        • FIGURE 10: PERCENTAGE OF U.S. INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
      • Developed Europe
        • TABLE 24: PERCENTAGE OF DEVELOPED EUROPEAN REGIONS--INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
        • FIGURE 11: PERCENTAGE OF DEVELOPED EUROPEAN REGIONS--INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
      • TABLE 25: GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 12: GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)

CHAPTER 6 - OUTPATIENT PHARMACY AUTOMATION

  • MARKET OVERVIEW
    • FIGURE 13: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, 2014-2021 ($ MILLIONS)
  • SETTING OVERVIEW
    • FIGURE 14: GLOBAL DRUG SALES MARKET SHARE, BY SELECTED COUNTRY, ESTIMATED 2015 (%)
    • Physician Office Visits
      • TABLE 26: UNITED STATES: MEDICATION THERAPY AND NUMBER OF MEDICATIONS MENTIONED AT OFFICE VISITS, 2012*
      • TABLE 27: DOCTORS' CONSULTATIONS BY COUNTRY, 2015*
    • Hospital Retail Settings
    • Pharmacy Benefit Management Services and Other Mail-Order Settings
      • TABLE 28: LEADING U.S. PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS/ MAIL-ORDER GROUPS' SALES ACTIVITY, 2015/2016 ($ BILLIONS)
    • Private and Managed Care PBMS
      • TABLE 29: UNITED STATES: PRIVATE AND MANAGED CARE ORGANIZATION PBM PARTICIPATION
    • PBM Acquisition and Merger Activity
      • Express Scripts and Medco Health Solutions
      • SXC Health Solutions and Catalyst Health Solutions
      • UnitedHealth Group and Catamaran Corp.
      • Walgreens and Drugstore.com
    • Retail Pharmacy Chains
      • TABLE 30: LEADING U.S. RETAIL PHARMACY CHAINS' SALES ACTIVITY (NUMBER/$ BILLIONS)
      • FIGURE 15: PHARMACY LOCATIONS BY PHARMACY CHAIN, 2008-2015 (NUMBER)
      • TABLE 31: U.S. RETAIL PHARMACY CHAINS: NUMBER OF LOCATIONS, BY STATE, 2015
  • MARKETS BY PRODUCT TYPE
    • TABLE 32: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 16: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014-2021 ($ MILLIONS)
  • PRODUCT DESCRIPTIONS
    • Automated Dispensing Systems
    • Automated Packaging/Filling Systems
    • Other Automated Systems
      • TABLE 33: SUMMARY OF OUTPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER AND EQUIPMENT TYPE
  • OUTPATIENT AUTOMATION COST BY EQUIPMENT TYPE
    • TABLE 34: OUTPATIENT PHARMACY AUTOMATION EQUIPMENT ANALYSIS
  • ADVANTAGES OF PHARMACY AUTOMATION FOR RETAILERS
    • MARKETS BY WORLD REGION
      • TABLE 35: GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET, BY REGION, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 17 GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARE, BY REGION, ESTIMATED 2016 (%)
      • Level of Automation within Outpatient Pharmacy Settings
        • United States
          • TABLE 36: PERCENTAGE OF U.S. OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
          • FIGURE 18: PERCENTAGE OF U.S. OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
        • Developed Europe
          • TABLE 37: PERCENTAGE OF DEVELOPED EUROPEAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
          • FIGURE 19: PERCENTAGE OF DEVELOPED EUROPEAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
      • TABLE 38: GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 20: GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET SHARE, ESTIMATED 2016 (%)

CHAPTER 7 - GLOBAL PHARMACY AUTOMATION MARKET SUMMARY

  • GLOBAL MARKET BY SEGMENT
    • TABLE 39: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • FIGURE 21: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, 2014-2021 ($ MILLIONS)
  • GLOBAL MARKET BY EQUIPMENT TYPE
    • TABLE 40: GLOBAL PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 22: GLOBAL PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014--2021 ($ MILLIONS)
  • GLOBAL MARKET SHARE BY SEGMENT
    • TABLE 41: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2014--2021 (%)
    • FIGURE 23: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2016 (%)
    • FIGURE 24: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2021 (%)
  • GLOBAL MARKET SHARES BY EQUIPMENT TYPE
    • TABLE 42: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2014--2021 ($ MILLIONS)
    • FIGURE 25: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2016 (%)
    • FIGURE 26: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2021 (%)
  • GLOBAL MARKET BY GEOGRAPHIC REGION
    • TABLE 43: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARE AND REVENUE, BY REGION, 2016 (%/$ MILLIONS)
    • FIGURE 27: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARE AND REVENUE, BY REGION, 2016 (%/$ MILLIONS)
    • FIGURE 28: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET GROWTH, BY REGION, 2016 AND 2021 ($ MILLIONS)
    • GLOBAL TRENDS
      • Mexico
      • Europe
      • Australia and New Zealand
      • Canada
      • Asia
      • Middle East
    • INDUSTRY PARTICIPANTS OVERVIEW
      • TABLE 44: GLOBAL PHARMACY AUTOMATION PARTICIPANT MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 29: GLOBAL PHARMACY AUTOMATION PARTICIPANT MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
      • FIGURE 30: MARKET PARTICIPATION BY VENDOR, CHANGE IN MARKET SHARE, 2016 VS 2021 (%)
      • TABLE 45: PHARMACY AUTOMATION MERGERS AND ACQUISITIONS*
    • INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE
      • TABLE 46: INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE, 2015/2016
      • TABLE 47: PHARMACY AUTOMATION EQUIPMENT PROVIDER PRODUCT LIST

CHAPTER 8 - TECHNOLOGY

  • OVERVIEW
  • CURRENT USES OF TECHNOLOGY
    • MEDICATION INSPECTION
    • COMMUNICATION NETWORK TECHNOLOGY
    • BIOMETRIC-TYPE IDENTIFICATION TECHNOLOGY
    • INFRARED TECHNOLOGY
    • AUTOMATED PARENTERAL DISPENSERS
    • BAR-CODE TECHNOLOGY
    • RADIO FREQUENCY IDENTIFICATION (RFID) TECHNOLOGY
    • AUTOMATED PHARMACY INVENTORY MANAGEMENT (PIM) SYSTEMS
    • AUTOMATED DISPENSING CABINETS (ADCS)
    • ROBOTICS
      • Linear Tracks
        • Sensor Technology
      • Programming Languages
        • User Interfaces
      • Graphic Image Interfaces
      • Guidance Systems
        • Fluorescent Guidepaths
          • Solvent-Borne Guidepaths
          • Water-Borne Emulsion Guidepaths
  • PATENT EVALUATION
    • PHARMACY AUTOMATION AND PHARMACY ROBOT PATENTS
      • TABLE 48: NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED, BY YEAR, 1995-2016
      • FIGURE 31: NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED, BY YEAR, 1995-2016* (NO.)
      • TABLE 49: PHARMACY AUTOMATION AND ROBOT PATENTS, BY ASSIGNEE, AS OF JUNE 2016
      • TABLE 50: PHARMACY AUTOMATION AND ROBOT PATENTS, BY ASSIGNEE, AS OF JUNE 2016 (NO. OF PATENTS)
    • PATENT HOLDER SUMMARY
      • Asteres
      • AutoMed Technologies
      • Intelligent Hospital Systems Ltd.
      • McKesson Automation
      • Medco Health Solutions/Express Scripts
      • Parata Systems
      • ScriptPro
      • Tech Pharmacy Services

CHAPTER 9 - COMPANY PROFILES

  • ARXIUM
  • BAXTER INTERNATIONAL INC.
    • TABLE 51: BAXTER INTERNATIONAL'S SUMMARY FINANCIALS, 2013-2015 ($ MILLIONS)
    • FIGURE 32: BAXTER INTERNATIONAL'S SUMMARY FINANCIALS, 2013-2015 ($ MILLIONS)
  • CAPSA SOLUTIONS LLC
  • BECTON, DICKINSON AND COMPANY
    • TABLE 52: BECTON DICKINSON'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • FIGURE 33: BECTON DICKINSON'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
  • CERNER CORP.
    • TABLE 53: CERNER'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • FIGURE 34: CERNER'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
  • EUCLID MEDICAL PRODUCTS
  • INNOVATION ASSOCIATES
  • MEDICAL PACKAGING INC.
  • OMNICELL INC.
    • TABLE 54: OMNICELL'S SUMMARY FINANCIALS, 2011--2015 ($ MILLIONS)
    • FIGURE 35: OMNICELL'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
  • PARATA SYSTEMS LLC
  • SCRIPTPRO LLC
  • SWISSLOG AG
    • TABLE 55: SWISSLOG'S SUMMARY FINANCIALS, 2011--2015 ($ MILLIONS)
    • FIGURE 36: SWISSLOG'S GROWTH SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
  • TALYST INC.
  • TCGRX

CHAPTER 10 - APPENDICES

  • APPENDIX I: LEADING EQUIPMENT MANUFACTURERS
    • AESYNT INC. (OMNICELL)
    • APOSTORE GMBH
    • ARXIUM CANADA
    • ASTERES INC.
    • BAXTER INTERNATIONAL INC.
    • BECTON, DICKINSON AND COMPANY
    • CAPSA SOLUTIONS LLC
    • CERNER CORP.
    • DIH TECHNOLOGIES CO.
    • DRUG PACKAGE INC.
    • ERGOTRON INC.
    • EUCLID MEDICAL
    • GLOBAL FACTORIES B.V.
    • HONEYWELL INTERNATIONAL INC.
    • INNOVATION ASSOCIATES
    • INTERMETRO INDUSTRIES CORP.
    • JONES PACKAGING INC.
    • KIRBY LESTER LLC.
    • KLS STEUERUNGTECHNIK GMBH
    • MANCHAC TECHNOLOGIES LLC
    • MANREX LTD.
    • MCKESSON PHARMACY SYSTEMS LLC
    • MEDICAL PACKAGING INC.
    • MEDITEC PTY LTD.
    • OMNICELL INC.
    • PARATA SYSTEMS
    • PEARSON MEDICAL TECHNOLOGIES LLC
    • ROBOPHARMA B.V.
    • RUBBERMAID HEALTHCARE
    • RXSAFE LLC
    • RX SYSTEMS INC.
    • SCRIPTPRO LLC
    • SUPPLY POINT SYSTEMS LTD.
    • SUZHOU IRON TECHNOLOGY CO. LTD.
    • SWISSLOG HOLDING AG
    • SYNERGY MEDICAL
    • TALYST INC.
    • TCGRX
    • TOSHO CO. INC.
    • WEBSTERCARE (MANREX)
    • YASKAWA ELECTRIC CORP.
    • YUYAMA CO. LTD.
  • APPENDIX II: OTHER RELATED COMPANIES
    • ALLERGAN PLC
    • AMERICAN ASSOCIATED PHARMACIES
    • AMERISOURCEBERGEN CORP.
    • ASTRAZENECA PLC
    • BECKMAN COULTER INC.
    • BRISTOL-MYERS SQUIBB CO.
    • CARDINAL HEALTH INC.
    • DIEBOLD INC.
    • ENOVATE MEDICAL
    • FRESENIUS KABI AG
    • GLAXOSMITHKLINE PLC
    • IBM CORP.
    • IMPINJ INC.
    • INTERMEC
    • KIRO ROBOTICS S.L.
    • KUKA AG
    • LUCIANO PACKAGING TECHNOLOGIES INC.
    • MICROSOFT CORP.
    • NEW COMPOUNDING PHARMA GMBH
    • NOVARTIS INTERNATIONAL AG
    • PAR EXCELLENCE SYSTEMS INC.
    • PERRIGO CO.
    • PFIZER INC.
    • PHARMITAS INC.
    • SYSTECH CORP.
    • TAGSYS USA
    • WAVEMARK INC.
  • APPENDIX III: ASSOCIATIONS AND ORGANIZATIONS
    • AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
    • AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
    • AMERICAN HOSPITAL ASSOCIATION
    • AMERICAN PHARMACISTS ASSOCIATION
    • ANVISA-BRAZILIAN HEALTH SURVEILLANCE AGENCY
    • AUSTRALIAN DEPARTMENT OF HEALTH
    • AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE
    • CANADIAN INSTITUTE FOR HEALTH INFORMATION
    • CENTERS FOR DISEASE CONTROL AND PREVENTION
    • CENTERS FOR MEDICARE AND MEDICAID SERVICES
    • CENTRAL DRUGS STANDARD CONTROL ORGANIZATION
    • CHINA FOOD AND DRUG ADMINISTRATION
    • DRUG ENFORCEMENT ADMINISTRATION
    • EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL (ECDC)
    • EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS
    • EUROPEAN MEDICINES AGENCY
    • EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION (EMCDDA)
    • EUROPEAN PATENT OFFICE
    • FEDERAL TRADE COMMISSION
    • FOOD AND DRUG ADMINISTRATION
    • HEALTH CANADA
    • INSTITUTE FOR SAFE MEDICATION PRACTICES
    • JAPANESE MINISTRY OF HEALTH, LABOUR, AND WELFARE
    • THE JOINT COMMISSION
    • NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
    • NATIONAL PATIENT SAFETY AGENCY
    • OHIO DEPARTMENT OF MENTAL HEALTH
    • OREGON STATE BOARD OF PHARMACY
    • ROYAL PHARMACEUTICAL SOCIETY
    • THERAPEUTIC GOODS ADMINISTRATION (TGA)
    • U.S. BUREAU OF LABOR STATISTICS
    • U.S. CENSUS BUREAU
    • U.S. DEPARTMENT OF DEFENSE
    • U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
    • U.S. PATENT AND TRADEMARK OFFICE
  • APPENDIX IV: STATE CONTROLLED SUBSTANCES SCHEDULING AUTHORITIES AND OTHER CONTACT INFORMATION

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: LIST OF ABBREVIATIONS USED IN MEDICAL PRESCRIPTIONS AND POSSIBLE CONFUSION MEANINGS
    • TABLE 2: ELECTRONIC HEALTHCARE "MEANINGFUL USE" STAGES BY CMS, 2011-2016
    • TABLE 3: AVERAGE ANNUAL ADVERSE DRUG REACTIONS AND MEDICATION ADMINISTRATION ERRORS
    • TABLE 4: WIDELY REPORTED TYPES OF MEDICATION ERRORS
    • TABLE 5: BENEFITS OF PRESCRIPTION MONITORING PROGRAMS FOR MEDICAL BOARDS
    • TABLE 6: STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS
    • TABLE 7: PERCENTAGE OF OFFICE-BASED PHYSICIANS USING ANY ELECTRONIC HEALTH RECORDS OR ELECTRONIC MEDICAL RECORDS, BY STATE, 2014* (%)
    • TABLE 8: HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP, BY COUNTRY, 2008--2014 (%)
    • TABLE 9: PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES, BY COUNTRY, 2005--2013 (%)
    • TABLE 10: PHARMACEUTICAL EXPENDITURES PER CAPITA, BY COUNTRY, 2005--2013 ($)
    • TABLE 11: BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%)
    • TABLE 12: LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015
    • TABLE 13: TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY AT AGE 65, 2015 (%)
    • TABLE 14: PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)
    • TABLE 15: HOSPITAL UTILIZATION STATISTICS, 2003 AND 2013 (NO. OF DAYS)
    • TABLE 16: ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE, BY SELECTED COUNTRY, 2015
    • TABLE 17: LONG-TERM CARE AND NURSING HOMES BEDS AND RECIPIENTS, BY SELECTED COUNTRY, 2015 (NUMBER)
    • TABLE 18: HOSPICE FACTS, 2011-2014
    • TABLE 19: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 20: SUMMARY OF INPATIENT PHARMACY AUTOMATION EQUIPMENT, BY MANUFACTURER AND EQUIPMENT TYPE
    • TABLE 21: INPATIENT PHARMACY AUTOMATION EQUIPMENT ANALYSIS
    • TABLE 22: GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET, BY REGION, ESTIMATED 2016 (%/$ MILLIONS)
    • TABLE 23: PERCENTAGE OF U.S. INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • TABLE 24: PERCENTAGE OF DEVELOPED EUROPEAN REGIONS--INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • TABLE 25: GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
    • TABLE 26: UNITED STATES: MEDICATION THERAPY AND NUMBER OF MEDICATIONS MENTIONED AT OFFICE VISITS, 2012*
    • TABLE 27: DOCTORS' CONSULTATIONS BY COUNTRY, 2015*
    • TABLE 28: LEADING U.S. PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS/ MAIL-ORDER GROUPS' SALES ACTIVITY, 2015/2016 ($ BILLIONS)
    • TABLE 29: UNITED STATES: PRIVATE AND MANAGED CARE ORGANIZATION PBM PARTICIPATION
    • TABLE 30: LEADING U.S. RETAIL PHARMACY CHAINS' SALES ACTIVITY (NUMBER/$ BILLIONS)
    • TABLE 31: U.S. RETAIL PHARMACY CHAINS: NUMBER OF LOCATIONS, BY STATE, 2015
    • TABLE 32: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 33: SUMMARY OF OUTPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER AND EQUIPMENT TYPE
    • TABLE 34: OUTPATIENT PHARMACY AUTOMATION EQUIPMENT ANALYSIS
    • TABLE 35: GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET, BY REGION, ESTIMATED 2016 (%/$ MILLIONS)
    • TABLE 36: PERCENTAGE OF U.S. OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • TABLE 37: PERCENTAGE OF DEVELOPED EUROPEAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • TABLE 38: GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET, ESTIMATED 2016 (%/$ MILLIONS)
    • TABLE 39: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 40: GLOBAL PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 41: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2014--2021 (%)
    • TABLE 42: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2014--2021 ($ MILLIONS)
    • TABLE 43: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARE AND REVENUE, BY REGION, 2016 (%/$ MILLIONS)
    • TABLE 44: GLOBAL PHARMACY AUTOMATION PARTICIPANT MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
    • TABLE 45: PHARMACY AUTOMATION MERGERS AND ACQUISITIONS*
    • TABLE 46: INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE, 2015/2016
    • TABLE 47: PHARMACY AUTOMATION EQUIPMENT PROVIDER PRODUCT LIST
    • TABLE 48: NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED, BY YEAR, 1995-2016
    • TABLE 49: PHARMACY AUTOMATION AND ROBOT PATENTS, BY ASSIGNEE, AS OF JUNE 2016
    • TABLE 50: PHARMACY AUTOMATION AND ROBOT PATENTS, BY ASSIGNEE, AS OF JUNE 2016 (NO. OF PATENTS)
    • TABLE 51: BAXTER INTERNATIONAL'S SUMMARY FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 52: BECTON DICKINSON'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • TABLE 53: CERNER'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • TABLE 54: OMNICELL'S SUMMARY FINANCIALS, 2011--2015 ($ MILLIONS)
    • TABLE 55: SWISSLOG'S SUMMARY FINANCIALS, 2011--2015 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, 2014-2021 ($ MILLIONS)
    • FIGURE 1: OPIOID ANALGESIC OVERDOSE DEATHS, 1999 VS 2014 (NO. OF DEATHS)
    • FIGURE 2: NUMBER OF STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS, BY YEAR OF ENACTMENT, 1990--2012 (NO. OF STATES)
    • FIGURE 3: HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP, BY COUNTRY, 2008--2014* (%)
    • FIGURE 4: HOSPITAL UTILIZATION STATISTICS, 2003 AND 2013 (NO. OF DAYS)
    • FIGURE 5: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, 2014--2021 ($ MILLIONS)
    • FIGURE 6: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET SHARE, BY END USER, ESTIMATED 2016 (%)
    • FIGURE 7: ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS, BY SELECTED COUNTRY, 2015
    • FIGURE 8: GLOBAL INPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 9: GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARE, BY REGION, ESTIMATED 2016 (%)
    • FIGURE 10: PERCENTAGE OF U.S. INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • FIGURE 11: PERCENTAGE OF DEVELOPED EUROPEAN REGIONS--INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • FIGURE 12: GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
    • FIGURE 13: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, 2014-2021 ($ MILLIONS)
    • FIGURE 14: GLOBAL DRUG SALES MARKET SHARE, BY SELECTED COUNTRY, ESTIMATED 2015 (%)
    • FIGURE 15: PHARMACY LOCATIONS BY PHARMACY CHAIN, 2008-2015 (NUMBER)
    • FIGURE 16: GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 17: GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARE, BY REGION, ESTIMATED 2016 (%)
    • FIGURE 18: PERCENTAGE OF U.S. OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • FIGURE 19: PERCENTAGE OF DEVELOPED EUROPEAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2015 (%)
    • FIGURE 20: GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET SHARE, ESTIMATED 2016 (%)
    • FIGURE 21: GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET, BY SEGMENT, 2014-2021 ($ MILLIONS)
    • FIGURE 22: GLOBAL PHARMACY AUTOMATION MARKET, BY EQUIPMENT TYPE, 2014--2021 ($ MILLIONS)
    • FIGURE 23: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2016 (%)
    • FIGURE 24: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY SEGMENT, 2021 (%)
    • FIGURE 25: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2016 (%)
    • FIGURE 26: GLOBAL PHARMACY AUTOMATION MARKET SHARE, BY EQUIPMENT TYPE, 2021 (%)
    • FIGURE 27: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARE AND REVENUE, BY REGION, 2016 (%/$ MILLIONS)
    • FIGURE 28: GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET GROWTH, BY REGION, 2016 AND 2021 ($ MILLIONS)
    • FIGURE 29: GLOBAL PHARMACY AUTOMATION PARTICIPANT MARKET SHARE AND REVENUE, ESTIMATED 2016 (%/$ MILLIONS)
    • FIGURE 30: MARKET PARTICIPATION BY VENDOR, CHANGE IN MARKET SHARE, 2016 VS 2021 (%)
    • FIGURE 31: NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED, BY YEAR, 1995-2016* (NO.)
    • FIGURE 32: BAXTER INTERNATIONAL'S SUMMARY FINANCIALS, 2013-2015 ($ MILLIONS)
    • FIGURE 33: BECTON DICKINSON'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • FIGURE 34: CERNER'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • FIGURE 35: OMNICELL'S SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
    • FIGURE 36: SWISSLOG'S GROWTH SUMMARY FINANCIALS, 2011-2015 ($ MILLIONS)
Back to Top